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Abstract
This review focuses on thiol=disulfide redox switches that regulate heme binding to proteins and modulate their
activities. The importance of redox switches in metabolic regulation and the general mechanism by which redox
switches modulate activity are discussed. Methods are described to characterize heme-binding sites and to assess
their physiological relevance. For thiol=disulfide interconversion to regulate activity of a system, the redox process
must be reversible at the ambient redox potentials found within the cell; thus, methods (and their limitations) are
discussed that can address the physiological relevance of a redox switch. We review recent results that define a
mechanism for how thiol=disulfide redox switches that control heme binding can regulate the activities of an
enzyme, heme oxygenase-2, and an ion channel, the BK potassium channel. The redox switches on these proteins
are composed of different types of Cys-containing motifs that have opposite effects on heme affinity, yet have
complementary effects on hypoxia sensing. Finally, a model is proposed to describe how the redox switches on
heme oxygenase-2 and the BK channel form an interconnected system that is poised to sense oxygen levels in the
bloodstream and to elicit the hypoxic response when oxygen levels drop below a threshold value. Antioxid. Redox
Signal. 14, 1039–1047.
Introduction
Redox homeostasis is essential for growth and sur-vival. Like cellular buffers that maintain the pH in a
suitable range, the ambient intracellular redox potential is
buffered and regulated by the ratio of several thiol=disulfide
systems, including thioredoxin, glutathione, and cysteine.
Cysteine residues within proteins also play an important role
as thiol=disulfide redox defense systems against oxidative
stress (25). Thus, the ratios of the intracellular concentrations
of the oxidized versus reduced states of these redox buffers
poise the ambient redox potential. Yet, what is ambient can be
ambiguous, because intracellular redox buffers are not fully in
equilibrium and seem to regulate the redox status of different
subsets of proteins (33, 43). Further, the intracellular ambi-
ent redox poise varies as the metabolic state of the cell chan-
ges. On the basis of the intracellular glutathione=glutathione
disulfide ratio, the redox poise ranges from*250mV when
cells are rapidly dividing to *200mV when they are dif-
ferentiating to *160mV when undergoing apoptosis (43).
Different compartments within the cell alsomaintain different
ambient potentials; for example, based on the thioredoxin
redox poise, the cytoplasm, nucleus, and mitochondria ex-
hibit redox potentials of 280, 300, and 340mV, respec-
tively (33). In addition, thiol=disulfide redox systems are
also important in altering (as well as maintaining) the redox
potential of the extracellular environment; for example, ex-
tracellular redox remodeling is important in controlling the
activation and proliferation of T cells within the immune
system (65). Thus, because redox poise is spatially and tem-
porally dynamic, systems are required to sense and to re-
spond to changes in ambient redox potential as well as to
coordinate events that occur under discrete redox conditions.
Redox switches and sensors are poised to respond to the
dynamic redox environment within the cell. A switch is an
electrical component that opens or closes a circuit, thus regu-
lating the flow of current to a light bulb, a machine, etc. By
analogy, a redox switch is a biochemical component that un-
dergoes a reversible redox change that controls activity by pro-
moting activation=inhibition of an enzyme, enhancement=
reduction of transcriptional activity, alteration in ligand binding
affinity, etc. A redox sensor is defined as a switch that addi-
tionally measures the ambient redox potential. Any biological
molecule that is redox active could potentially serve as a redox
switch or redox sensor. Aswell as cysteine thiol=disulfide (Cys-
SS-Cys=CysSH), which is the focus of this review, the list of
potential redox switches or sensors includes, CysSH=Cys-
sulfonate, transition metal ions (Fe3þ=2þ, Ni2þ=1þ, Cu2þ=1þ,
iron-sulfur clusters, etc.); cofactors like flavins (FAD=
FADH8=FADH2), folate (folate=H2folate=H4folate), NAD(P)
þ=
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NAD(P)H, and quinones (Q=QH8=QH2); and redox equilib-
rium between the oxidized and reduced states of small mole-
cules like glutathione, CoA, and mycothiol (20).
This review focuses on thiol=disulfide redox switches that
interconvert between the oxidized disulfide and the reduced
thiol(ate) states (Eq. 1) and, as a result of this redox change,
bind their ligandwith higher or lower affinity. A related redox
switch involves interconversion between the sulfenic acid and
thiol states (Eq. 2). As described in Poole’s article in this vol-
ume (36), when there is a nearby reactive Cys residue, that is, a
resolving Cys, the sulfenate can undergo conversion to the
disulfide. Thus, as indicated by summing Equations 2 and 3,
interconversion between the thiol and disulfide states can
involve a sulfenate intermediate. Because the sulfenate can
undergo facile irreversible oxidation eventually to the sulfo-
nate, the presence of a resolving Cys residue helps tomaintain
a reversible two-electron redox interconversion.
RSSRþ 2 Hþ þ 2 e $ 2 RSH (1)
RS -OHþ 2 Hþ þ 2 e $ RSHþH2O (2)
RS -OHþRSH$ RSSRþH2O (3)
Switches and Redox Coupling
Figure 1 illustrates how a redox switch can regulate activity
(ligand binding, a chemical reaction, etc), or, similarly, how
activity can alter the apparent redox potential of the switch.
The fraction of the reduced component of the redox switch has
been plotted versus the ambient redox potential of the solution
in which the reaction occurs. The two parameters obtained
from this Nernst plot are the number of electrons (n) trans-
ferred and the midpoint redox potential (E0) for the reaction.
E0 represents the potential at which the concentrations of
oxidized and reduced species are equal. The plot is described
by the Nernst equation (Eq. 4), where R is the universal gas
constant (8.31 J K1 mol1), T is the absolute temperature, F is
the Faraday constant (9.65104 Cmol1), and n is the number
of electrons transferred in the reaction. Thus, the curve on the
left would represent any two-electron reaction, for example,
Equation 1, with an E0 of*185mV.
Any redox-active biological molecule can potentially serve
as a redox switch; however, for the redox interconversion to
be physiologically relevant, the midpoint redox potential of
the Aox=Ared couple must be near the range of the ambient
intracellular redox potential, which ranges from 170 to
325mV (17, 32). Thus, the redox switch shown in Figure 1
would appear to be physiologically relevant, because the
midpoint potential (*185mV) is within the range of the
ambient intracellular redox potential.
Figure 1 also describes what happens when a redox pro-
cess is coupled to a chemical process, which might be a
redox-dependent conformational change, a binding event, or
a chemical reaction, which is classed by an electrochemist as
an EC system. In this example, only the reduced form of the
enzyme can bind its ligand (B), thus lowering the concentra-
tion of Ared and shifting the apparent E
0 to more positive
values. Themagnitude of the shift relates to how favorable the
coupled reaction is. For example, reduction of Co2þ is a very
unfavorable reaction; however, in methionine synthase this
reaction can be accomplished at relatively mild redox poten-
tials because it is coupled to the binding of methyltetrahy-
drofolate and conversion of Co1þ to methyl-Co3þ (4).
E¼E0 RT
nF
ln
[Ared]
[Aox]
(4)
Various processes in proteins have been shown to respond
to redox changes. Redox-dependent transcriptional activation
or repression is observed in several systems (3). OxyR, SoxR,
and CprK are redox switches that control transcription in
response to oxidative stress in bacteria (3, 14, 23, 26, 49).
Exposure of cells to H2O2 leads to the formation of a disulfide
bond in OxyR, which activates the transcription of genes that
are part of a peroxide regulon and are involved in defense
against oxidative stress. In SoxR, the oxidation or nitrosyla-
tion of a [2Fe-2S] cluster is coupled to a conformational change
that is linked to transcriptional activation of oxidative stress
defense genes. In the case of CprK, only the reduced state of a
thiol=disulfide switch can promote a conformational change
that activates transcription of genes involved in dehalogena-
tion of haloaromatic environmental pollutants, a process that
requires two oxygen-sensitive cofactors: vitamin B12 and an
iron–sulfur cluster (13).
The same types of redox changes and redox-sensitive
modules that modulate transcriptional activity can also elicit
changes in catalytic activity of an enzyme. As described in the
article by Becker and coworkers, profound redox-dependent
changes occur in PutA (8). In its reduced state, PutA is a
membrane-bound proline dehydrogenase; however, upon
oxidation, the enzyme is released from the membrane to
become a transcriptional repressor of genes involved in pro-
line utilization (8, 74). As described in more detail below, a
thiol-disulfide redox switch inmammalian heme oxygenase-2
(HO2) regulates the binding of its substrate (Fe3þ-heme).
Similarly, for the mammalian voltage- and Caþþ-activated
large conductance potassium channel (BK channel), the thiol-
disulfide redox switch controls the affinity of a regulatory site
for heme, which is an allosteric inhibitor of Kþ transport.
Thus, redox switches can couple redox processes occurring
in redox-responsive modules to events in other functional
FIG. 1. Comparison of standard redox reactions (left) and
an EC reaction (right) in which a redox process is coupled
to a chemical reaction. B binds to (or reacts with) only the
Ared state. Because only the reduced form of the protein can
bind ligand, the apparent redox potential of the Eox=Ered
couple shifts to a more positive value.
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domains, allowing the regulation of transcription, enzymatic
activity, ion channel activity, membrane binding, etc. This
coupling allows the cell to maintain metabolic homeostasis
and effect metabolic changes under varying redox conditions,
as exemplified by the various systems described in this forum
issue on redox switches.
Measurement of the Thiol=Disulfide
Midpoint Redox Potential
The midpoint redox potential of the thiol=disulfide couple
can be measured by several methods. Regardless of the
technique, it is important to ensure that the Cys residues are in
redox equilibrium with the solution, because thiols and dis-
ulfides usually are sluggish to equilibrate. Redox mediators
with midpoint potentials in the range of the couple to be
determined are used to establish and maintain the ambient
potential of the solution (the x-axis of Fig. 1). Common me-
diators are dithiothreitol (E0¼327mV) (39) and glutathione
(E0¼240mV) (54). For example, the reduced form of glu-
tathione=oxidized disulfide state of glutathione ratio can be
varied to establish a gradient of ambient redox potentials
between 130 and 250mV.
Because onlyminor changes in theUV–visible spectrum are
associated with the thiol=disulfide interconversion, continu-
ous UV–visible spectroelectrochemical measurements are
usually too insensitive to monitor the redox titration. On the
other hand, if a Trp residue is near the targeted Cys residues,
fluorescence methods can often be used to continuously
monitor the redox status of the thiol=disulfide couple, because
the disulfide generally quenches the intrinsic fluorescence of a
nearby excited Trp residue by an electron transfer mecha-
nism (52). Thus, with this type of redox titration, the y-axis of
Figure 1 would represent the extent of fluorescence quench-
ing. Direct electrochemistry, performed by attaching the
proteins directly to electrodes, is another option for continu-
ous measurements of the extent of oxidation=reduction at
varied redox potentials (15).
Discontinuous methods are also available to measure the
midpoint potential of a thiol=disulfide redox switch. The
ambient potential is set by incubation of the sample with a
redox buffer as in the continuous methods described above;
however, it is important to ensure that the redox state of the
Cys residue(s) established by the redox buffer system is
trapped and does not change during preparation of the
samples for the redox measurement. Treatment with ice-cold
trichloroacetic acid is often used for thiol trapping (40) before
the samples are reacted with a thiol modification reagent, for
example, maleimide, iodoacetate, and vinylpyridine. Then,
the extent of modification can be monitored by a polyacryl-
amide gel-basedmethod, such as themaleimide-polyethylene
glycol 5000 thiol-trapping method, which places a 5 kDa
adduct on each free thiol on the protein (68).
In Vivo Measurements of the Thiol=Disulfide Ratio
Besides the above-mentioned in vitromethods, one can also
measure the ratio of oxidized=reduced Cys by an in vivo or ex
vivo method. This measurement is an important test of the
hypothesis that the particular redox switch is physiologically
relevant. This is a more demanding experiment than the
in vitro measurement with a purified protein because the
protein of interest is only one component of all other proteins
in the cell and because the desire is to trap the thiol status
under a particular metabolic condition, for example, hypoxia,
normoxia, and peroxide stress. The isotope coded affinity tag
(ICAT) method is a novel mass spectrometric technique that
combines thiol trapping with the ICAT technique to quantify
oxidative thiol modifications within the growing cell (40).
ICAT reagents consist of an iodoacetamide group linked to a
cleavable biotin affinity tag via an isotopically light (12C) or
heavy (13C) nine-carbon linker (24). Briefly, cells are lysed at
low pH to trap the thiol status and then reacted with the
light ICAT reagent. After washing to remove the first re-
agent, the precipitated protein sample is reduced with tris
(2-carboxyethyl)phosphine and all newly reduced thiols are
alkylated with heavy ICAT reagent. The alkylated proteins
are then digested with typsin, and the cysteine containing
peptides are enriched on a cation-exchange cartridge followed
by an avidin affinity cartridge to enrich the tagged peptides.
Finally, the samples are analyzed by liquid chromatography
followed by tandem mass spectrometry to quantify the
amounts of reduced (dithiol) protein conjugating the light
ICAT reagent and oxidized (disulfide) protein conjugating the
heavy ICAT reagent.
Thiol=Disulfide Redox Regulation of Heme Binding
and Activity of HO2 and the BK Channel
The methods and principles described above have been
used to characterize the thiol=disulfide redox switches in HO2
and the BK channel, which form an integrated system to sense
oxygen and hypoxia. The switches in both proteins modulate
activity by regulating ligand (heme) binding.
Catalyzing the rate-limiting step in heme catabolism to
generate CO, biliverdin, and free iron, heme oxygenase (HO,
EC 1:14:99:3) is a key regulator of heme and iron homeostasis.
HO is linked to various signaling pathways and is important
in the response to oxidative stress (1, 7). In cyanobacteria,
algae, and plants, HO and biliverdin reductase are involved in
generating phytochromes, which modulate growth and pho-
tosynthesis (53, 63). The HO-catalyzed degradation of heme
requires three oxygenation cycles and seven electrons pro-
vided by cytochrome P450 reductase (Eq. 5). Then, biliverdin is
transformed to bilirubin by biliverdin reductase. In animals,
HO is the only known significant source of the signaling
molecule CO (35).
Fe3þ -hemeþ 3 NADPHþ 3O2 ! Fe2þ þCOþBiliverdin
þ 3NADPþ þ 3H2O (5)
Mammals (in fact, all amniotes) contain two HO isoforms:
inducible HO1 and constitutively expressed HO2. HO1 and
HO2 share similar physical and kinetic properties; however,
they have different tissue distributions, with HO2 being
highly expressed in the brain, testes, and carotid body (41).
HO1 and HO2 share a high level of sequence (55% identity
and 76% similarity, as indicated by the middle shaded region
in Fig. 2) and structural homology within their core catalytic
domains. The heme is sandwiched between the distal and
proximal helices (37, 55), the latter of which donates a histi-
dine ligand to the heme iron (His25 inHO1 andHis45 in HO2)
(Fig. 2). HO1 (33 kDa) and HO2 (36 kDa) have similar
molecular masses, comparable enzymatic activities, and share
a stretch of 20 hydrophobic residues at their C-terminus that
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forms a transmembrane helix that anchors them to the
microsomal membrane (41). There are two divergent regions
between HO1 and HO2. The first is an *20 residue exten-
sion at the N-terminus of HO2. The other is a region near the
C-terminus (between residues 240–295, HO2 numbering),
which contains two heme responsive motifs (HRMs) (Fig. 2).
Early studies on HO2 indicated that heme binds to each of the
HRMs (42); however, more recent studies clearly demonstrate
that the HRMs in HO2 do not bind heme per se, but instead
form a thiol=disulfide redox switch that is involved in regu-
lating the affinity of HO2 for a single heme that binds to the
catalytic domain (70). HO2 also contains a third HRM; how-
ever, its role (if any) is unknown. In contrast, there are no Cys
residues in HO1.
HRMs are found in various proteins and are known to
control processes related to iron and oxidative metabolism in
organisms ranging from bacteria to humans. The HRM con-
sists of a conserved Cys-Pro core sequence that is usually
flanked at the N-terminus by basic amino acids and at the
C-terminus by a hydrophobic residue (Table 1). There are
three HRMs in both isozymes of aminolevulinate synthase
(the housekeeping enzyme aminolevulinate synthase-1 and
the erythroid tissue-specific enzyme aminolevulinate syn-
thase-2), which catalyzes the first and rate-limiting enzymatic
reaction in themammalian heme biosynthetic pathway. In the
transcriptional regulator, Bach1, HRMs are reported to bind
heme and thus inhibit its DNA-binding activity (11, 45). Three
HRMs, which have been proposed to control its activity and
stability, exist in iron responsive regulator (Irr) (50, 66, 67).
The yeast transcriptional activator Hap1 contains seven
HRMs that are proposed to mediate heme-dependent tran-
scriptional activation of genes that mediate the effects of ox-
ygen on transcription (27, 38). In HO2, the two C-terminal
HRMs constitute a thiol=disulfide redox switch that responds
to the intracellular redox potential (68) and regulates the heme
affinity of the enzyme (21, 70) (Fig. 3). Thus, HRM-heme in-
teractions regulate the activity and=or stability of proteins that
play central roles in respiration and oxidative damage (27, 38),
coordinate protein synthesis, and heme availability in retic-
ulocytes (13, 60) and control iron and heme homeostasis
(19, 42, 44, 67, 71).
We began to explore the role of the HRMs in HO2 because
they represent themajor obvious difference betweenHO1 and
HO2. The properties of HO2 variants containing single,
double, and triple Cys-to-Ala substitutions of the HRMs,
along with a truncated variant that lacks the entire HRM re-
gion, were compared with those of the wild-type protein in
both the oxidized and reduced states (70). In addition, thiol
modification experiments were performed to characterize the
redox state of each Cys residue under oxidizing and reducing
conditions. As summarized in Figure 3, under oxidizing
conditions, the two C-terminal HRMs were shown to form a
FIG. 2. Comparison of HO1 and HO2. (A) Organization of
HO1 and HO2. Conserved regions are shaded. (B)Overlay of
the core structures of HO1 (PDB 1N45) and HO2 (PDB
2QPP). The C-terminal region containing the HRMs, which
was not observed in the structure of HO2 is depicted as a
rectangle. The ‘‘?’’ indicates that the HRM region could not
be located in the electron density due to disorder. HO2, heme
oxygenase-2; HRM, heme responsive motif. (For interpreta-
tion of the references to color in this figure legend, the reader
is referred to the web version of this article at www
.liebertonline.com=ars).
Table 1. Heme Responsive Motifs in Various Proteins
Protein Species HRM sequence
Aminolevulinate synthase-1 Human RCPFLS, NCPKMM, KCPFLA
Aminolevulinate synthase-2 Human RCPVLA, RCPILA, HCPFML
Bach1–transcriptional regulator
of H01 expression
Human ECPRKK, DCPLSF, PCPYAC, NCPFIS,
ECPWLG, QCPEK, LCPKYR
eIF2 (eukaryotic Initiation Factor 2)
Kinase
Rabbit ACPYVM, RCPAQA
Hap1 Yeast KCPIMH, KCPVDH, RCPVDH, RCPVDH,
KCPVDH, RCPIDH, KCPVYQ
Heme oxygenase-2 Human KC265PFYA, SC282PFRT
IRP-2 Human LCPFHL
IRR (Iron Responsive Regulator) Gm negative bacteria GCPWHD
Per2 (Period-2 circadian regulator) Human SCPAVPF
This table lists the species from which the HRMs have been identified and does not imply that the CP (shown in bold face) motifs are not
conserved. For example, the HRMs in heme oxygenase-2 are conserved in all amniotes.
HRM, heme responsive motif.
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disulfide link that is reducible with glutathione or dithio-
threitol. A Cys sulfenate was characterized in the C127A=
C282A variant, indicating this as a possible intermediate in
oxidation of the dithiol to the disulfide. The redox state of the
HRMs and the Cys-to-Ala substitutions were shown to not
affect the stoichiometry of heme binding (one heme per mol
protein), stability, spectral properties of the heme (in the fer-
ric, ferrous, and ferrous-CO states), or activity at saturating
heme concentrations; however, the oxidized disulfide state
was shown to bind heme with*10-fold higher affinity than
that of the reduced dithiol state (70). Because heme binds
within the alpha helical core catalytic domain of HO2, which
is nearly identical to that of HO1, the HRM region must reg-
ulate heme affinity through allosteric effects.
Because HO2 is constituitively expressed, it is important to
understand how the levels of CO, heme, and bilirubin are
regulated in neurons and in other tissues in which HO2 is the
dominant HO isoform. We have proposed that the HRMs at
the C-terminus of HO2 play an important mode in regulating
HO2 activity and, in turn, cellular functions linked to HO2
and in integrating redox regulation with heme and CO me-
tabolism (68).
In accord with the hypothesis, the HRMs in HO2 do not
independently bind heme, but form a thiol=disulfide redox
switch that regulates affinity of the active site for heme (70).
The Kd value for the HO2-heme complex was found to be
around 350 nM when the cysteines of the HRMs are in the
reduced dithiol state; however, this value drops significantly
to*33 nM, similar to the intracellular free heme level, when
the HRMs switch to the oxidized disulfide state, indicating a
much stronger affinity of oxidized HO2 for its substrate.
Recent in vitro and ex vivo studies indicated the physiological
relevance of this redox switch (68). Using fluorescence
quenching and thiol trapping methods, the midpoint poten-
tial of the thiol=disulfide redox couple in HO2 (200mV) (68)
was shown to be within the 170 to 325mV range of the
ambient cellular redox potential. Then, by the OxICAT
method (described above), the redox state of the HRMs in
growing cells exposed to different redox conditions was as-
sessed. These studies demonstrated that the HRMs in HO2
respond to the cellular redox state with the disulfide state
predominating under oxidizing or oxidative stress conditions,
the dithiolate under reducing conditions, and an approxi-
mately equal mixture of the dithiol and disulfide states under
normoxic conditions (68).
A key function of HO2 that is linked to redox, heme, and
CO metabolism is to regulate the activity of the BK channel,
which functions in the carotid body to regulate oxygen sens-
ing and the hypoxic response (58). BK channels have the
largest single-channel conductance of all Kþ- selective chan-
nels and control neural firing patterns, modulate blood vessel
tone, and are an element of the electrical resonator in the inner
hair cells of the cochlea (16). BK channels are activated by
membrane depolarization and increases of intracellular Ca2þ
levels; therefore, activation of the BK channel repolarizes the
cell membrane and leads to closing of voltage-gated Ca2þ
channels, allowing it to serve as a key negative feedback
regulator of both membrane potential and intracellular Ca2þ
levels (16). Because membrane potential and Ca2þ levels
control so many physiological processes in various tissues,
dysfunction of the BK channel can lead to hypertension,
hearing loss, motor impairment, urinary problems, and
asthma (16).
As in other voltage-gated Kþ channels (depicted in Fig. 4),
the BK channel is composed of four pore-forming a subunits,
each of which contains a seven-helix transmembrane
segment, a voltage-sensing domain, one-fourth of the ion
conduction pore (2), and, at the C-terminal end, a large 700-
residue cytoplasmic region containing two regulators of
conductance of potassium (RCK1 and RCK2) domains that
are required for Ca2þ activation of the channel (64, 72). RCK1
also serves as a Hþ sensor (29, 72) and appears to be involved
in inhibition of the BK channel by heme and activation by CO
(58). It appears that heme, CO, and HO2 bind to a linker
region between the two RCK domains, which is called the
heme-binding domain (HBD) (69). BK channel activity is also
regulated by accessory b subunits, which can modulate volt-
age, Ca2þ, and Mg2þ sensitivity and are important for the
different functions of BK channels in various tissues (46, 59).
Recent results indicate that the BK channel is regulated by a
thiol=disulfide-mediated redox switch, within the HBD,
which is similar in principle to that just described for
HO2 (69). This HBD contains a characteristic CXXCH thi-
ol=disulfide regulatory motif in which the histidine resi-
due serves as the axial heme ligand. The CXXC forms a
thiol=disulfide redox switch that regulates the affinity of the
HBD for heme and CO. This is a rather robust switch in which
the dithiol state binds heme with a Kd (210 nM) that is similar
to the free heme pool, whereas the disulfide state has 14-fold
poorer affinity. The redox switches in these two proteins are
composed of different Cys-containing motifs—in HO2, two
C-terminal HRMs form the thiol=disulfide switch (above),
whereas a CXXC motif in the BK channel comprises its redox
FIG. 3. Regulation of heme binding by the HRMs in HO2.
Conversion from the thiol(ate) to the disulfide state appears to
involve a sulfenate intermediate (33). The oxidized disulfide
state hasmuch higher affinity for heme than the reduced state.
The midpoint redox potential for the SS=2RSH couple is
200mV (22). (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of
this article at www.liebertonline.com=ars).
REDOX REGULATION OF HEME BINDING 1043
switch. Further, the heme in the HBD tightly binds CO (Kd
50 nM) (69), which is significant because CO binding to the
BK channel has been shown to activate its potassium trans-
port activity (58, 62).
Figure 4 presents a two-tier model for regulation of the
activities of HO2 and the BK channel. It is proposed that, at
one level, the activities of HO2 and the BK channel are mod-
ulated by the redox state of the cell. An important component
of this model is that the thiol=disulfide redox switches in these
proteins exhibit similar midpoint redox potentials: 200mV
for HO2 (68) and 185mV for the BK channel (69). Another
key component of the model is that the thiol-disulfide redox
switches in HO2 and the BK channel exert opposite (but
complementary) effects on the affinity for heme. Thus, the
oxidized (disulfide) state of HO2 and the reduced (dithiol)
state of the BK channel would bind heme at the low concen-
trations found within the cell; however, heme would be re-
leased from reduced HO2 or oxidized BK channel. Figure 4
also proposes a second tier of regulation involving modula-
tion of the rate at which HO2 generates CO and the conse-
quent effect of this variation in local concentrations of CO on
BK channel activity.
As proposed in Figure 4, under normoxic conditions, there
is sufficient O2 present to poise the thiol=disulfide switches of
HO2 and the BK channel in the disulfide state, where HO2 has
high affinity and the BK channel has low affinity for heme.
Thus, under normoxic conditions, release of heme from the
BK channel would promote the open state and high Kþ
transport activity. Because O2 is a required substrate for HO2,
these O2-rich conditions favor production of CO, which
would react with any remaining heme bound to the BK
channel and activate Kþ transport. Conversely, under hypoxic
conditions, the lowO2 levels and low affinity of HO2 for heme
would result in low heme degradation and CO production
rates, thus increasing local heme levels and decreasing CO
concentrations. These conditions, coupled with the high
affinity of the BK channel for heme, would favor the inhibited
heme-bound state of the BK channel, poising the channel in
the closed state (represented by a cork stopper).
The second tier of regulation involves CO binding to the BK
channel. Figure 4 describes two recently proposed mecha-
nisms by which CO could mediate activation of the BK
channel. The first mechanism involves CO binding to heme
(31) in the HBD (69), whereas the other is a heme-independent
mechanism in which CO was proposed to activate the BK
channel by directly interacting with specific His and Asp
residues in the RCK1 domain (30). This mechanism was
proposed because mutation of these residues leads to loss of
CO-dependent activation. Because it is difficult to imagine
metal-independent CO binding, we favor the heme-depen-
dent mechanism and have suggested that the His=Asp resi-
dues in the RCK1 domain either bind a metal ion (that can
bind CO) or are involved in allosteric control of heme-
dependent CO binding (69).
Ultimately, inhibition of the BK channel results in a depo-
larization wave from the glomus cells of the carotid body to
the respiratory system, causing increased ventilation to
restore circulating blood O2 levels. Although, given all the
inputs to which the BK channel is sensitive, Figure 4 is un-
doubtedly a simplistic explanation for how the BK channel is
regulated by redox, heme, CO, and HO2, it provides a
working and testable hypothesis that redox poise and the
levels of heme andCO convergewith other known regulators,
for example, Caþþ and pH, to modulate BK channel activity.
Significance of HO2-Mediated Redox Regulation
of Heme and CO Homeostasis
CO, one of the three products of the HO-catalyzed reaction,
acts as a signaling molecule in various physiological pro-
cesses, including circadian modulation of heme biosynthesis,
regulating T cell function, modulating caveolin-1 status in
growth control (35), activating guanylate cyclase (5), and
mediating O2 sensing and the hypoxic response through
regulation of the BK channel (62), which enables the
O2-sensing function of the human carotid body (28, 34), as
FIG. 4. Model for redox regulation of HO2 and BK
channel activity. The membrane-spanning, HBD, RCK1,
RCK2, and C-terminal domains of the BK channel (one of the
four pore-forming a subunits is removed to show the internal
channel) are shown in interaction with HO2, which contains
a core catalytic domain that binds and metabolizes heme and
a C-terminal regulatory region that contains the thiol=
disulfide switch. The surface representation of HO2 is based
on its crystal structure, which lacks the redox switch, here
represented by two rectangles (9a). The cartoon of the BK
channel is loosely derived from its EM structure (61a). Under
normoxic conditions, the channel opens because inhibitor
heme has dissociated from the HBD (due to its low heme
affinity in the SS state) or because CO (generated by HO2)
is bound. Under hypoxic conditions, the channel is closed
because inhibitor heme is bound (due to the high affinity
of HBD for heme in its reduced RSH state) and because
CO levels are relatively low (due to low affinity of HO2 for
heme and to low O2 levels). Thus, heme is bound to HO2
under normoxic conditions and to the HBD of the BK channel
under hypoxia. HBD, heme-binding domain; RCK, regulator
of conductance of potassium. (For interpretation of the ref-
erences to color in this figure legend, the reader is referred
to the web version of this article at www.liebertonline
.com=ars).
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described above. Although both HO1 and HO2 catalyze CO
formation, the specific functions of HO2 are revealed in
studies of HO2 knockout mice, which are more susceptible to
neurotoxicity, cerebral ischemia, stroke damage, and trau-
matic brain injury, indicating an important role for HO2 in
neural signaling, neuroprotection (against oxidative stress in
brain injury), and in regulating cerebral blood flow (10, 12, 18,
51, 61, 73). A role of HO2 in traumatic brain injury is in
reducing lipid peroxidation (10). Cerebral microvascular
endothelial cells from HO2 knockout mice exhibit higher
sensitivity to TNF-a induced apoptosis and glutamate toxic-
ity, whereas bilirubin and CO rescue this defect (6, 47).
Because HO1 is not induced under these conditions, it
appears that HO2 is the key enzyme responding to TNF-a-
induced oxidative stress in this cell type (48). Similarly, HO2-
null corneas exhibit chronic inflammation that is attenuated
by supplementation with biliverdin (48, 56). Surprisingly,
even though HO1 is relatively more highly expressed in the
kidney than HO2, CO and biliverdin production decreases by
more than twofold in HO2= versus wild-type mice (9, 10,
57). Further, HO2 has been shown to protect against renal
pathology induced by oxidative stress related to diabetes (22).
Conclusion and Future Directions
This review covers a system composed of two interacting
proteins: HO2 and the BK channel. Thiol=disulfide redox
switches allosterically regulate both proteins by controlling
the binding of heme, which is a substrate for HO2 and an
allosteric inhibitor for the channel. Although the redox
switches in the two proteins are evolutionarily unrelated, a
CXXCH motif in the BK channel and HRMs in HO2, their
midpoint redox potentials are similar, 185 to 200mV,
which is well within the range of ambient intracellular redox
potential.
The scope of thiol=disulfide regulation of heme binding is
not known and it is expected to reach to other systems. One
approach is to combine experimental methods, like OxICAT,
and in silico methods to identify all proteins that contain
thiol=disulfide switches with midpoint potentials within the
range of the intracellular ambient redox potential. Similarly,
methods might be developed to identify all proteins that
allosterically and reversibly bind heme at physiologically
relevant concentrations. Thus, such heme-regulated proteins
should have Kd values for heme in the 20–150 nM range of the
free heme poise within cells, allowing them to bind and re-
lease heme as a function of an external signal (redox, etc.). It is
also important to identify the thiol=disulfide exchange fac-
tors or oxidoreductases that can partner with the redox
switches. Another layer of regulation is observed in the BK
channel, which although inhibited by heme, undergoes acti-
vation by CO. It will be interesting to examine how many
heme- and redox-regulated systems are also subject to another
tier of regulation by binding gaseous messengers like CO,
NO, and H2S.
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